WuXi Biologics
Offering End-to-End Solutions
Clients worldwide
Ongoing, integrated CMC development programs*
Ongoing late-stage, integrated (Phase II / III) programs*
Successful INDs filed by our clients, enabled through WuXi XDC services
*Integrated programs comprise product development and manufacturing programs contracted to us by our clients that utilize multiple WuXi XDC development capabilities / technologies or services (e.g., cell line development, process development, analytical development, formulation and drug product development etc.) and GMP manufacturing (drug substance, drug product or both)
“Linking innovation to health” by offering an open-access platform with the most comprehensive capabilities and technologies in the global ADC (antibody drug conjugate) and XDC (other novel bioconjugate) industry.
To continuously enhance our platform, propel and transform the development of the bioconjugate industry, enable global biopharmaceutical partners and benefit patients worldwide.
Customer focus
Positive attitude and energy
Continuous learning
Tackling tough tasks
Embracing change
Giving back to society
Accountability
Excellence and efficiency
Honesty and Ethics
Diversity and inclusion
Respect and communication
Teamwork
Strong execution
GROWTH mindset
Calculated risks
As a leading global open-access biologics technology platform, WuXi XDC is committed to the highest standards of ethics and integrity. We strive to deal honestly, ethically and fairly with our customers, suppliers, employees, competitors, and the communities we serve worldwide. WuXi XDC does not engage in false, misleading, deceptive or fraudulent statements for our products and services. We are dedicated to conducting business only with individuals and organizations who share our commitment to the highest ethical standards and operate in a socially and environmentally responsible manner.
In line with that commitment, the Company expects and encourages its employees, customers, suppliers and other stakeholders who have concerns about any suspected misconduct or malpractice within the Company to come forward and voice those concerns through the whistleblowing channel.
Compliance reporting: IA_biologics@wuxibiologics.com, Compliance_Biologics@wuxibiologics.com
WuXi XDC, as a subsidiary of WuXi Biologics, adheres to all business ethics, code of conduct and IP policies as established by WuXi Biologics.
Our purpose in business is to enable innovation for our global partners, who keep us at the top of their confidence. IP is our shared lifeline. We guard it at WuXi Biologics with our founding principles of integrity, world-class security, zero tolerance policies, and relentless pursuit of justice against any criminal act. This is our highest priority, and we must hold ourselves accountable. We are determined to earn the trust of our partners by committing to success together.
We are dedicated to implementing sustainable and eco-friendly business practices by building a comprehensive and integrated Environmental, Health and Safety (EHS) management system, sourcing ethically, reducing our environmental footprint, advocating reduced energy consumption, minimizing effluent, and acting responsibly to reduce operational impact on the environment.
On our Diversity, Equity and Inclusion initiatives, we strive to advance a diverse workforce and create an equal and inclusive corporate culture. To this end, we recruit employees based on their professional and academic achievements regardless of religion, disability, age, race, color, sex, gender identity, sexual orientation, or marital status to provide equal employment opportunity.
Along with the creation of our own compliance management system and ethical standards training programs for all employees, our “Zero tolerance” for bribery and corruption principles along with our commitment to honesty and trustworthy business conduct promote our ESG culture.
The WuXi XDC ESG report can be found here.
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?
